ODDB.org: Open Drug Database

Cheplapharm Schweiz GmbH - De-ursil RR 450 mg, Hartkapseln, retardiert

Swissmedic Registration	44619	Sequence	01
Product name	De-ursil RR 450 mg	Description	Hartkapseln, retardiert
ATC-Classification	A05AA02	ATC-Description	Ursodeoxycholic Acid
Introduction of Sequence	28.06.1983

Composition

acidum ursodeoxycholicum 450 mg, talcum, cellulosum microcristallinum, carmellosum natricum conexum, carmellosum natricum, E 218 0.18 mg, gelatina, sorbitolum 2.82 mg, povidonum K 90, magnesii stearas, Überzug: acidi methacrylici et methylis methacrylatis polymerisatum 1:1, tributylis citras, acidi methacrylici et ethylis acrylatis polymerisatum 1:1, acidi methacrylici et methylis methacrylatis polymerisatum 1:2, macrogolum 6000, E 171, E 172 (rubrum), talcum, Kapselhülle: gelatina, pro capsula corresp. natrium 0.66 mg.

Packungsbestandteile

Galenic Form

Capsules

Excipiens

Active Agent	Dose
Ursodeoxycholic Acid	450 mg

BAG: Active Agent	Dose
Ursodeoxycholic Acid	450 mg

Inactive agents	Dose	additional_information
(Rubrum)
Acidi Methacrylici
Carmellose Sodium
Carmellosum Natricum Conexum
Cellulosum Microcristallinum
E 171		color.
E 172		color.
E 218	0.18 mg	conserv.
Ethylis Acrylatis Polymerisatum
Gelatina
Macrogol	6000
Magnesii Stearas
Methylis Methacrylatis Polymerisatum
Povidonum K	90
Sorbitol	2.82 mg
Talcum
Tributylis Citras

Package number	Package Size	EFP	CP	Category	SL	Out of trade (MedRef)
005	10	PR	PR	B		Yes
006	20	27.07	45.85	B	SL	Yes
007	60	75.86	98.90	B	SL	Yes

2025	©ywesee GmbH